For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

 

Crossref Citations

1. Fidaxomicin Use in the Pediatric Population with Clostridioides difficile
Meredith B Oliver, Byron P Vaughn
Clinical Pharmacology: Advances and Applications  vol: Volume 14  first page: 91  year: 2022  
doi: 10.2147/CPAA.S273318

2. Clostridioides difficile infection and testing rates in South Africa: A multicentre study, 2017–2020
Trusha Nana, Praksha Ramjathan, Khine Swe-Swe Han, Kessendri Reddy
Anaerobe  vol: 91  first page: 102937  year: 2025  
doi: 10.1016/j.anaerobe.2024.102937

3. Phenotypic and genotypic antimicrobial resistance profiles of clinical Clostridioides difficile isolates collected from private and public health settings in South Africa
Hlambani Shirinda, Anthony M. Smith, Mohamed Said, Ben Prinsloo, Mishalan Moodley, Marleen M. Kock, Marthie M. Ehlers
European Journal of Clinical Microbiology & Infectious Diseases  vol: 44  issue: 10  first page: 2439  year: 2025  
doi: 10.1007/s10096-025-05205-6

4. Clostridioides difficile resistance to antibiotics, including post-COVID-19 data
Lyudmila Boyanova, Georgi Dimitrov, Raina Gergova, Petyo Hadzhiyski, Rumyana Markovska
Expert Review of Clinical Pharmacology  vol: 16  issue: 10  first page: 925  year: 2023  
doi: 10.1080/17512433.2023.2252331

5. Risk Factors Associated with Suspected Clostridium difficile Infection (CDI) in Elderly Diarrhea Patients at Prof. Dr. I.G.N.G. Ngoerah Hospital
I Gusti Putu Suka Aryana, Ni Nyoman Sri Budayanti, Ni Luh Putu Harta Wedari
Indonesian Journal of Tropical and Infectious Disease  vol: 11  issue: 3  year: 2023  
doi: 10.20473/ijtid.v11i3.47664